Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 13159601000001113 | Zantac 75 tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 13174001000001115 | Zantac 75 tablet (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Zantac 75 tablet | Is a | Ranitidine 75mg tablet | false | Inferred relationship | Existential restriction modifier | ||
| Zantac 75 tablet | NHS prescribing status | NHS prescribable | false | Additional relationship | Existential restriction modifier | ||
| Zantac 75 tablet | Legal category | Pharmacy Medicine | false | Additional relationship | Existential restriction modifier | ||
| Zantac 75 tablet | Product name type | Brand name | false | Additional relationship | Existential restriction modifier | ||
| Zantac 75 tablet | Availability | Product is currently available | false | Additional relationship | Existential restriction modifier | ||
| Zantac 75 tablet | CSM recommendation to report adverse reactions | Report only serious adverse reactions to the Committee on Safety of Medicines | false | Additional relationship | Existential restriction modifier | ||
| Zantac 75 tablet | Has active ingredient | Ranitidine | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR